Anew Medical Statistics Share Statistics Anew Medical has 21.26M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 21.26M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 12.71M Failed to Deliver (FTD) Shares 691 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 135.71K, so 0% of the outstanding
shares have been sold short.
Short Interest 135.71K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.09
Valuation Ratios The PE ratio is 43.34 and the forward
PE ratio is null.
Anew Medical's PEG ratio is
0.63.
PE Ratio 43.34 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 5.2 P/FCF Ratio -46.2 PEG Ratio 0.63
Financial Ratio History Enterprise Valuation Anew Medical has an Enterprise Value (EV) of 59.77M.
EV / Sales 0 EV / EBITDA -45.95 EV / EBIT -47.33 EV / FCF -47.33
Financial Position The company has a current ratio of 0.09,
with a Debt / Equity ratio of 0.14.
Current Ratio 0.09 Quick Ratio 0.09 Debt / Equity 0.14 Debt / EBITDA -1.23 Debt / FCF -1.27 Interest Coverage 0
Financial Efficiency Return on Equity is 12% and Return on Invested Capital is -5%.
Return on Equity 12% Return on Assets 6.92% Return on Invested Capital -5% Revenue Per Employee n/a Profits Per Employee $1.35M Employee Count 1 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 690.57K Effective Tax Rate 33.91%
Stock Price Statistics The stock price has increased by -10.98% in the
last 52 weeks. The beta is 0.02, so Anew Medical's
price volatility has been higher than the market average.
Beta 0.02 52-Week Price Change -10.98% 50-Day Moving Average 0.85 200-Day Moving Average n/a Relative Strength Index (RSI) 32.25 Average Volume (20 Days) 1,794,992
Income Statement
Revenue n/a Gross Profit n/a Operating Income -1.3M Net Income 1.35M EBITDA -1.3M EBIT n/a Earnings Per Share (EPS) 0.14
Full Income Statement Balance Sheet The company has 172.53K in cash and 1.6M in
debt, giving a net cash position of -1.43M.
Cash & Cash Equivalents 172.53K Total Debt 1.6M Net Cash -1.43M Retained Earnings -7.35M Total Assets 3.31M Working Capital 101.27K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.26M
and capital expenditures 0, giving a free cash flow of -1.26M.
Operating Cash Flow -1.26M Capital Expenditures n/a Free Cash Flow -1.26M FCF Per Share -0.13
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
